Simvastatin News
More People Could Benefit From Statins
Study Shows Lipid-Lowering Drugs Cost-effective for Most Patients.
Cadila wins tentative nod for generic Zocor
Cadila Healthcare Ltd. announced on Tuesday that it has received tentative approval from the US Food & Drug Administration (US FDA) to market Simvastatin Tablets, 5 mg, 10 mg, 20 mg, 40 mg and 80mg., in the US market.
Merck 3rd-Quarter Profit Falls on Zocor Competition
Merck & Co.'s third-quarter profit declined 34 percent as cheaper copies of its Zocor cholesterol pill, the company's best-selling product, eroded sales.
FDA Approves New Label for VYTORIN(R) (ezetimibe/simvastatin)
Merck/Schering-Plough Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the inclusion of new data in the product label that showed VYTORIN(R) (ezetimibe/simvastatin) was more effective...
Life after statin patent expiries
The American Heart Association estimates that 34.5 million adults in the US have high cholesterol, and a further 100 million are thought to have levels considered borderline to high. A greater understanding of the causes and...